Please login to the form below

Not currently logged in
Email:
Password:

progressive supranuclear palsy

This page shows the latest progressive supranuclear palsy news and features for those working in and with pharma, biotech and healthcare.

Celgene bulks up pipeline again with $2.1bn Prothena deal

Celgene bulks up pipeline again with $2.1bn Prothena deal

The three targets at the centre of the collaboration with Ireland-based Prothena include: tau protein, already a focus in Alzheimer’s research and other conditions like progressive supranuclear palsy (PSP);

Latest news

  • AbbVie takes anti-tau drug into phase II for Alzheimer's AbbVie takes anti-tau drug into phase II for Alzheimer's

    drugs. The antibody - called ABBV-8E12 - is being tested in two phase II trials, one in patients with early Alzheimer's and a second in progressive supranuclear palsy (PSP), a rare ... We see potential in ABBV-8E12 and tau-focused approaches to

  • AbbVie and C2N take tau antibody into clinic AbbVie and C2N take tau antibody into clinic

    AbbVie and C2N take tau antibody into clinic. Treatment being assessed for a progressive neurodegenerative disorder. ... The first-in-class therapy - called C2N-8E12 or ABBV-8E12 - is being tested in patients with the rare neurodegenerative disorder

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    IPN007 is being developed in the first instance for progressive supranuclear palsy (PSP), a serious neurodegenerative disorder that progresses much more quickly than Alzheimer's but is also characterised by tau

  • CNS drug wins orphan status

    CNS drug wins orphan status. Drug-development company Mithridion has won orphan status from the US Food and Drug Administration for a potential treatment for brain disease progressive supranuclear palsy. ... The clinical-stage drug-development company

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics